Expression of TRK-T1 oncogene induces differentiation of PC12 cells

Cell Growth Differ. 1993 Jul;4(7):539-46.

Abstract

The TRK-T1 oncogene, isolated from a human thyroid carcinoma, represents a rearranged form of the high affinity nerve growth factor (NGF) receptor encoded by the NTRK1 gene; it is created by an intrachromosomal rearrangement fusing the NTRK1 tyrosine kinase domain to the 5' portion of the TPR gene. We have investigated the effect of the TRK-T1 oncogene in PC12 cells, a model system for studying neuronal differentiation and the mechanism of action of NGF. Here, we report that, in PC12 cells, the TRK-T1 oncogene has a differentiating effect that resembles that of NGF and requires the phosphorylation of the oncoprotein. Our results are consistent with the hypothesis that TRK-T1, as well as the original TRK oncogene, induces PC12 differentiation by mimicking the action of NGF bound to its receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Carbazoles / pharmacology
  • Cell Differentiation / genetics
  • Gene Expression / drug effects*
  • Genetic Vectors
  • Indole Alkaloids
  • Molecular Sequence Data
  • Nerve Growth Factors / pharmacology*
  • Neurons / cytology*
  • Oncogenes / physiology*
  • PC12 Cells
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Receptor, trkA
  • Receptors, Nerve Growth Factor / antagonists & inhibitors
  • Transfection / physiology

Substances

  • Carbazoles
  • Indole Alkaloids
  • Nerve Growth Factors
  • Proto-Oncogene Proteins
  • Receptors, Nerve Growth Factor
  • staurosporine aglycone
  • Receptor Protein-Tyrosine Kinases
  • Receptor, trkA